Software & Developer Tools
ADmit Therapeutics
ADmit Therapeutics is a series a startup. 1 investor tracked.
Activeseries-c-plus
series-c-plus
Stage
2020
Founded
4
Investors
About ADmit Therapeutics
ADmit Therapeutics is a company founded in 2020 headquartered in Spain. Its most recent tracked round is Series C+. Brouky classifies it under Software & Developer Tools. Brouky records 4 investors associated with the company.
ADmit Therapeutics develops an early detection test for Alzheimer's disease based on epigenetic analysis in blood samples using next-generation sequencing, enabling identification of Alzheimer's and acceleration of curative drug development.
Explore ADmit Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.